Navigation Links
Xylene Cyanole FF from Sigma-Aldrich
Concentrated Epitope Retrieval Buffer-Reduced pH from Bethyl Laboratories
GIBCO Donor Calf Serum from Invitrogen
...agicMark XP Western Protein Standards are specific...cular weight estimation directly on western blots....e, allowing direct visualization with the same ant...t protein on the blots. Colorimetric, chemilumines...
Genetic Mapping of Disease Genes from Promega
Biology Products:
(Date:12/2/2009)...only prescribed beta 2 adrenergic agonist drugs fo...l as pre-term labor may increase the incidence of ...cognitive problems and poor school performance in ... in the December 2009 issue of the American Journ...gic agonist drugs as a class are widely used in ob...
(Date:12/2/2009)...ding to the National Institute of Health, 40 perce...tes already have some stage of diabetic retinopath...sed by leaky blood vessels, is a major cause of bl...most feared diabetic complications. In fact, up t...or 10 years or more will experience some form of d...
(Date:12/1/2009)...d to announce the publication of results from its ... and tolerability of its novel, intranasal drug/de...rhinosinusitis with nasal polyps in Rhinology , t...ean Rhinologic Societies. , Chronic rhinosinusi...n significantly reduce a patient,s quality of life...
Breaking Biology News(10 mins):Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Congressional Health Reform Bill Falls Short on Comprehensive and Affordable Coverage for Low Income Children 61194 1Congressional Health Reform Bill Falls Short on Comprehensive and Affordable Coverage for Low Income Children 61194 2Congressional Health Reform Bill Falls Short on Comprehensive and Affordable Coverage for Low Income Children 61194 3Memphis Mayor Endorses National Bipolar Foundation 61190 1Memphis Mayor Endorses National Bipolar Foundation 61190 2YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS 14798 1YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS 14798 2YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS 14798 3YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS 14798 4YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS 14798 5YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS 14798 6YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS 14798 7YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS 14798 8YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS 14798 9YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS 14798 10YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS 14798 11YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS 14798 12
...pothesis that combination antiretroviral drug ther...nsmission through breastfeeding, findings that cou... world. , Researchers in the first study found mot...reastfeeding infants in concentrations high enough...els of HIV RNA in breast milk are lower in mothers...
...essor of physics at Virginia Tech, has been awarde... from Oak Ridge Associated Universities to continu...s modeling the sequence of events that initiate ac...ce it has reached a critical size. , The Powe awar... who are in the first two years of their tenure tr...
...rely on their healthcare providers to learn about ...ir doctor has talked to them about cervical cancer...according to a new survey released by the Associat...PV is extremely common, affecting an estimated 80 ...e, in some cases staying dormant until years after...
Other Biology News:Antiretroviral Therapy May Prevent HIV Transmission From Breastfeeding Mothers To Infants 2Antiretroviral Therapy May Prevent HIV Transmission From Breastfeeding Mothers To Infants 3Understanding how bacteria communicate may help scientists prevent disease 2Understanding how bacteria communicate may help scientists prevent disease 3Survey reveals women and doctors aren't talking about HPV 2Survey reveals women and doctors aren't talking about HPV 3
(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*BIO... novel oral JAK2 inhibitor, SB1518, at The America...position in New Orleans. ,, Data will be presen...escalation trial of SB1518 detailing its safety, t...K/PD) profile in dose levels ranging from 100 to 6...
(Date:12/2/2009)... The Scientist, a leading scient...hotometrics’ Evolve “Intelligent&rdquo...s “Top 10 Innovations of 2009. , ...lve ™ EMCCD camera from Photometrics ®...CCD and EMCCD cameras for the life sciences, was r...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Report...port is available in its catalogue: ,, Industr...//www.reportlinker.com/p0164431/Industrial-Enzymes...nzymes market is an oligopoly with few strong play... market activities. Keen competition and commoditi...
(Date:12/1/2009)... , SHANGHAI, Dec. 1 /PRNewswire-Asia/ -- Sh...ShangPharma, a leading China-based Contract Resear...ner of the 2009 Deloitte,Technology Fast 50 China,...gh,tech companies in China. The award is a testame... growth from 2006 to 2008. , The results ...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3